PACS Group (PACS) vs Tenet Healthcare (THC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
PACS Group (PACS) has outperformed Tenet Healthcare (THC) over the past year, gaining 224.7% versus a gain of 26.9%. Tenet Healthcare is the larger company by market cap ($20.92 billion vs $6.84 billion), about 3.1 times the size, while PACS Group is growing revenue faster (+29.3% vs +3.1%). On valuation, Tenet Healthcare trades at a lower forward P/E (12.3x vs 15.8x for PACS Group).
Tenet Healthcare converts more of its revenue into profit, with a net margin of 11.1% versus 3.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PACS | THC |
|---|---|---|
| Share price | $43.19 | $259.83 |
| Market cap | $6.84B | $20.92B |
| 1-day change | +0.89% | +0.53% |
| YTD return | +12.50% | +30.75% |
| 1-year return | +224.74% | +26.85% |
| 5-year return | — | +308.79% |
| P/E ratio (TTM) | 25.26 | 10.01 |
| Forward P/E | 15.81 | 12.32 |
| EPS (TTM) | $1.71 | $25.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.29B | $21.31B |
| Revenue growth (YoY) | +29.32% | +3.07% |
| Net income (latest FY) | $191.54M | $2.37B |
| Gross margin | 21.92% | — |
| Operating margin | 5.85% | 16.46% |
| Net margin | 3.62% | 11.11% |
| 52-week high | $49.49 | $283.05 |
| 52-week low | $10.31 | $157.58 |
| Distance from 52-week high | -12.73% | -8.20% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +36.61% | +9.81% |
| Average volume | 804.85K | 978.02K |
| Shares outstanding | 158.34M | 80.52M |
| Employees | 47,455 | 77,000 |
| Sector | Health Care | Health Care |
| Industry | Hospital/Nursing Management | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Tenet Healthcare is about 3.1 times larger than PACS Group by market value ($20.92B vs $6.84B).
- PACS has outperformed THC by 197.9 percentage points over the past year.
- PACS Group trades at a higher earnings multiple (25.3x vs 10.0x trailing P/E).
- Tenet Healthcare is more profitable, keeping 11.1 cents of every revenue dollar as net income versus 3.6 cents for PACS Group.
- PACS Group grew revenue faster in its latest fiscal year (+29.32% vs +3.07%).
About PACS Group
PACS stock →PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities.
Health Care · Hospital/Nursing Management · 47,455 employees
About Tenet Healthcare
THC stock →Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care.
Health Care · Hospital/Nursing Management · 77,000 employees
PACS vs THC FAQ
Which is bigger, PACS Group or Tenet Healthcare?
Tenet Healthcare (THC) is larger, with a market capitalization of $20.92B compared with $6.84B for PACS Group (PACS).
Which stock has performed better over the past year, PACS or THC?
PACS returned +224.74% over the past 12 months, compared with +26.85% for THC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PACS or THC?
THC has the lower trailing P/E at 10.0, versus 25.3 for PACS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are PACS Group and Tenet Healthcare in the same industry?
Yes. Both are classified in the Hospital/Nursing Management industry within the Health Care sector.